Search
Search Results
- Author(s):
- Brownlee, Shannon, author
- Publication:
- Oakland, CA : California HealthCare Foundation, [2013]
- Subject(s):
- Hospice Care -- statistics & numerical data
Hospital Mortality
Neoplasms -- mortality
Palliative Care -- statistics & numerical data
Terminal Care -- statistics & numerical data
Antineoplastic Agents -- therapeutic use
Forecasting
Hospice Care -- trends
Intensive Care Units -- statistics & numerical data
Intensive Care Units -- trends
Medicare
Neoplasms -- drug therapy
Palliative Care -- trends
Terminal Care -- trends
Time Factors
Humans
California
United States
United States. Food and Drug Administration.
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011
- Subject(s):
- Antimetabolites, Antineoplastic -- administration & dosage
Antimetabolites, Antineoplastic -- adverse effects
Medication Errors
Methotrexate -- administration & dosage
Methotrexate -- adverse effects
Data Collection
Neoplasms -- drug therapy
Humans
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, July 2022
- Subject(s):
- Clinical Trials as Topic
Government Regulation
Neoplasms -- drug therapy
United States
United States. Food and Drug Administration
- Author(s):
- Kohn, Kurt W., author
- Publication:
- Bethesda, Maryland : National Cancer Institute, [2022]
- Subject(s):
- Antineoplastic Agents -- history
Drug Discovery -- history
Neoplasms -- drug therapy
United States
Kohn, Kurt W.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
- Subject(s):
- Clinical Trials as Topic -- ethics
Adolescent
Neoplasms -- drug therapy
Adult
Medical Oncology -- ethics
Patient Safety
Patient Selection
Pharmacokinetics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
- Subject(s):
- Clinical Trials as Topic
Prognosis
Research Design
Biomarkers, Pharmacological
Biomarkers, Tumor
Captopril -- therapeutic use
Cardiovascular Diseases -- drug therapy
Clozapine -- therapeutic use
Cyclooxygenase 2 Inhibitors -- therapeutic use
Drugs, Investigational
Lung Diseases -- drug therapy
Medication Adherence
Neoplasms -- drug therapy
Patient Compliance
Patient Selection
Pharmacogenetics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, May 2019
- Subject(s):
- Antineoplastic Agents -- adverse effects
Mutagenicity Tests -- standards
Neoplasms -- drug therapy
Reproduction -- drug effects
Teratogens
Toxicity Tests -- standards
Contraception
Drug-Related Side Effects and Adverse Reactions
Fertility
Geriatrics
Pediatrics
Postmenopause
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
- Subject(s):
- Drug Evaluation, Preclinical -- standards
Neoplasms -- drug therapy
Radiopharmaceuticals -- pharmacology
Toxicity Tests
Carcinogenicity Tests
Drug Labeling
Lactation -- drug effects
Pharmacokinetics
Radiation Dosage
Animals
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
- Subject(s):
- Double-Blind Method
Neoplasms -- drug therapy
Placebos
Randomized Controlled Trials as Topic -- standards
Single-Blind Method
Antineoplastic Agents
Biological Products
Randomized Controlled Trials as Topic -- ethics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2023
- Subject(s):
- Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Neoplasms -- drug therapy
United States